The official blog of the Lung Institute.

Lung Institute to Open New Clinic in Scottsdale in February 2015

20 Jan 2015
| Under Press | Posted by

SCOTTSDALE, AZ- In February 2015, the Lung Institute will open a new clinic in Scottsdale, AZ. This expansion marks its third location in the country. With cellular therapy centers already in Tampa and Nashville, the Lung Institute has made positive impacts in the lives of their patients and the surrounding communities.

The Lung Institute is committed to providing patients with an effective way to treat pulmonary conditions, rather than just manage their symptoms, which results in an improvement in their overall quality of life. Their application of innovative technology combined with advanced cellular therapys enables them to carry out their mission and successfully provide world-class care to their patients who visit the Lung Institute from across the globe.

The Lung Institute treats conditions such as COPD, pulmonary fibrosis, chronic bronchitis, emphysema, and interstitial lung disease.

The addition of this treatment center will create jobs in the medical, sales, and administrative industries. Additionally, local businesses, and the medical tourism industry of the Scottsdale area will benefit, as most patients travel for treatment. By utilizing their full-service patient coordinator services, The Lung Institute plans to actively promote all that Scottsdale has to offer as an ancillary benefit to obtaining advanced treatment for lung disease.

A ribbon cutting ceremony will be held at the new facility with the medical staff, Lung Institute corporate team, community representatives, and members of the Scottsdale and Phoenix Chambers of Commerce in attendance. The new facility is located at 8377 East Hartford Drive in Scottsdale, and will be open for treatment beginning on February 9, 2015.

“We are very excited to join the vibrant Scottsdale community,” says Lynne Flaherty, Executive Vice President of the Lung Institute, “Through cellular therapy, we hope to offer patients an alternative method to treat their lung disease while enjoying an exceptional local environment.”

About the Lung Institute

At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life.  Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive cellular therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.